会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明公开
    • 개체의 산 관련 질병의 위험도를 검사하는 방법
    • 检测个体酸性相关疾病风险的方法
    • KR1020050057220A
    • 2005-06-16
    • KR1020057003839
    • 2003-09-05
    • 바이오히트 오와이제이
    • 수오바니에미오스모하르코넨마티시포넨펜티
    • G01N33/53G01N33/573G01N33/74G01N33/68
    • G01N33/56922G01N33/573G01N2333/205G01N2333/595
    • The present invention is directed to a method for detecting a risk of gastric acid related disease in an individual based on assaying the analytes pepsinogen I, fasting gastrin-17 and a marker for Helicobacter pylori infection (Hp-marker), the method comprising selecting a cut-off value for pepsinogen I, fasting gastrin-17 and the Hp- marker, determining the concentration of pepsinogen I, fasting gastrin-17 and the concentration or presence of a Hp-marker in a sample from said individual, andcomparing the concentrations so determined with the selected cut-off values, whereby a pepsinogen I value at or above its respective cut-off value in combination with a Hp-marker value below its respective cut-off value and a fasting gastrin-17 value at or below its cut-off is indicative of an increased risk of gastric acid-related disease in said individual.
    • 本发明涉及一种基于测定分析物胃蛋白酶原I,空腹胃泌素-17和幽门螺杆菌感染(Hp-标记)的标记物来检测个体胃酸相关疾病风险的方法,所述方法包括选择 胃蛋白酶原I,空腹胃泌素-17和Hp标记的临界值,确定胃蛋白酶原I,空腹胃泌素17的浓度,以及来自所述个体的样品中Hp标记的浓度或存在,并比较浓度 用所选择的截止值确定,其中胃蛋白酶原I值等于或高于其各自的临界值,结合Hp-标记值低于其各自的临界值,以及在其切口处或其下方的空腹胃泌素-17值 -off表明在所述个体中胃酸相关疾病的风险增加。
    • 72. 发明授权
    • 씨형 간염바이러스 복제효소의 활성측정방법
    • 씨형간염바이러스복제효소의활성측정방법
    • KR100462328B1
    • 2004-12-17
    • KR1020020009304
    • 2002-02-21
    • 주식회사 엘지생명과학
    • 이미경김정민조영규노기윤김경원김태균조우영조동규
    • G01N33/573
    • PURPOSE: A method for measuring activity of hepatitis C virus replicase is provided, thereby automatically carrying out HTS(High-throughput screening) analysis using SPA(Scintillation proximity assay)-based screening technologies. CONSTITUTION: A method for measuring activity of hepatitis C virus replicase comprises the steps of: mixing substrates containing isotope-labeled substrate, HCV(hepatitis C virus) replicase, SPA beads, biotin-15-UTP as a primer, poly A-500 as a template RNA, and buffer solution; carrying out the polymerization using the mixture; and measuring activity of HCV replicase using a liquid scintillation counter, wherein the isotope labeled substrate comprises 5,6-3H-UTP and another UTP; the SPA bead is streptavidin-SPA bead; and inhibitors of the polymerization process contain dimethylsulfoxide.
    • 目的:提供一种测量丙型肝炎病毒复制酶活性的方法,从而使用基于SPA(闪烁邻近测定)的筛选技术自动进行HTS(高通量筛选)分析。 构成:测定丙型肝炎病毒复制酶活性的方法包括以下步骤:将含有同位素标记的底物,HCV(丙型肝炎病毒)复制酶,SPA珠粒,生物素-15-UTP作为引物,聚A-500的底物 模板RNA和缓冲溶液; 使用混合物进行聚合; 并使用液体闪烁计数器测量HCV复制酶的活性,其中同位素标记的底物包含5,6-3H-UTP和另一种UTP; SPA珠是链霉亲和素-SPA珠; 并且聚合过程的抑制剂含有二甲基亚砜。
    • 73. 发明公开
    • 1,5-안하이드로글루시톨의 정량 분석법 및 시약
    • 定量测定1,5羟基喹啉和试剂的定量测定方法
    • KR1020000048041A
    • 2000-07-25
    • KR1019990056195
    • 1999-12-09
    • 교와 메덱스 가부시키가이샤
    • 다조에사까에미이께아끼라
    • G01N33/573
    • PURPOSE: A method of quantitative assay for 1,5-anhydroglucitol(AG) and reagent for such quantitative assay are provided to accomplish a simple method of measuring 1,5-AG by substantially and completely removing or eliminating the glucose contained in a specimen. CONSTITUTION: A method of quantitative assay for 1,5-anhydroglucitol(AG) and reagent comprises the steps of converting a glucose into fructose-1,6-diphosphate, allowing an enzyme system for converting 1,5-AG into 1,5-AG-6-phosphate to contact the specimen, dehydrogenizing the 1,5-AG-6-phosphate contained in the specimen by an action of 1,5-AG-6-phosphate dehydrogenase in the presence of the oxidized coenzyme, and measuring the amount of the resultant reduced coenzyme formed by the dehydrogenation.
    • 目的:提供一种定量测定1,5-脱水葡萄糖醇(AG)和这种定量测定试剂的方法,以实现通过基本上和完全去除或消除样品中所含的葡萄糖来测量1,5-AG的简单方法。 构成:1,5-脱水葡萄糖醇(AG)和试剂的定量测定方法包括将葡萄糖转化为果糖-1,6-二磷酸的步骤,使酶系统将1,5-AG转化为1,5- AG-6-磷酸酯接触样品,在1,5-AG-6-磷酸脱氢酶的作用下,在氧化型辅酶的存在下使包含在试样中的1,5-AG-6-磷酸脱氢,并测量 通过脱氢形成的所得还原型辅酶的量。